Prostate Cancer
Luteinizing-hormone-releasing-hormone causes prostatic atrophy
Published in Clinical Oncology Week, November 22nd, 2004
"Previous studies with a semi-synthetic vaccine indicated the utility of immunization against luteinizing-hormone-releasing-hormone (LHRH) in prostate cancers. To overcome the limitations of the previous vaccine, which caused carrier induced suppression of antibody response on repeated immunizations and was costly to synthesize, two recombinant vaccines were designed, in which diphtheria or tetanus toxoid used as carriers were replaced by 4-5 T non-B peptides," scientists in India report.
"The paper reports the immunogenicity, efficacy and safety...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Bladder Cancer
Study shows COMBIDEX aids in diagnosis of metastatic lymph nodes - Breast Cancer
Disease and therapy can result in thoracic changes - Cervical Cancer
Plasma HPV DNA may be useful to monitor therapy and disease progression - Oncogenesis
Adenoma to carcinoma hTR expression not linked to promoter methylation - Acute Myelogenous Leukemia
Phenotypic karyotype markers identified in AML with t(8;21) - Air Quality
Smoke-free workplace laws provide protection impossible to achieve otherwise - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
